Study Name:

A Trial of Single Autologous Transplant With or Without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients With Multiple Myeloma.

 

 

 

         

Purpose:

The study is designed as a phase III, multicenter trial of tandem autologous transplants plus maintenance therapy versus the strategy of single autologous transplant plus consolidation therapy with lenalidomide bortezomib and dexamethasone (RVD) followed by maintenance therapy or single autologous transplant plus maintenance therapy as part of upfront treatment of multiple myeloma (MM).

Study Type: Treatment

Protocol: UIC 2010-0636 BMT CTN 0702

 

For study details, click here.

Internal users only: click here for protocol details and forms.

Back to Oncology Clinical Trials Homepage